Nachrichten zur Johnson & Johnson Aktie

Johnson & Johnson Tops Q2 Estimates

Key PointsAdjusted EPS reached $2.77 in Q2, topping estimates by $0.09, but fell year over year.Revenue rose 5.8% year over…

Dows 110-point rally highlighted by gains in Johnson & Johnson, Amgen shares

The Dow Jones Industrial Average is up Wednesday afternoon with shares of Johnson & Johnson and Amgen seeing positive momentum…

Stocks making the biggest moves midday: Morgan Stanley, ASML, Johnson & Johnson, SolarEdge and more

These are the stocks posting the largest moves in midday trading.…

Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool. DATEWednesday, July 16, 2025 at 8:30 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Joaquin DuatoChief…

Johnson & Johnson Q2 Earnings Review: This Is As Safe As Pharma Investing Gets

…

Wall Street: Nvidia und Johnson & Johnson stehen zum Auftakt im Fokus

Die US-Börsen zeigen sich am Mittwoch uneinheitlich: Während der Dow Jones oder 0,3 Prozent zulegt und der S&P 500 um…

Wall Street: Nvidia und Johnson & Johnson stehen zum Auftakt im Fokus

Die US-Börsen zeigen sich am Mittwoch uneinheitlich: Während der Dow Jones oder 0,3 Prozent zulegt und der S&P 500 um…

Market movers: Johnson & Johnson, Morgan Stanley, Bit Digital...

…

Johnson & Johnson (JNJ) Reports Q2 Earnings: What Key Metrics Have to Say

The headline numbers for Johnson & Johnson (JNJ) give insight into how the company performed in the quarter ended June…

Johnson & Johnson Aktie: Zölle wohl doch nicht so schlimm

Wien (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von der Raiffeisen Bank International AG: Raphael Schicho, Analyst der Raiffeisen Bank International AG (RBI),…

Geschäfte mit Medizintechnik treibt Johnson & Johnson an - Prognosen angehoben

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) blickt nach einem überraschend guten zweiten Quartal zuversichtlicher auf das…

Geschäfte mit Medizintechnik treibt Johnson & Johnson an - Prognosen angehoben

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) blickt nach einem überraschend guten zweiten…

Stocks making the biggest moves premarket: Goldman Sachs, ASML, Diageo, Johnson & Johnson and more

These are the stocks posting the largest moves in premarket trading.…

3 Magnificent S&P 500 Dividend Stocks Down 16% to 20% to Buy and Hold Forever

Key PointsDividend stocks are one of the most powerful investing tools to build wealth. The S&P 500 has plenty of…

Johnson & Johnson beats profit estimates on strong Darzalex, medtech sales

Johnson & Johnson reported second-quarter profit and raised its full-year sales forecast by around $2 billion on Wednesday as strong…

Johnson & Johnson delivers earnings beat, raises full year sales and profit guidance

Johnson & Johnson (NYSE:JNJ) shares edged higher premarket as the healthcare firm reported an earnings beat for the second quarter…

Johnson Controls names Chris Scalia as new HR chief By Investing.com

Johnson Controls names Chris Scalia as new HR chief…

10 Dividend Stocks to Double Up On Right Now

Key PointsDividend stocks have historically outperformed non-dividend payers. Several companies have excellent records of paying a growing dividend. Theyre worth…

Want to Generate at Least $1,000 in Passive Income Per Year? Invest $26,000 in This Dividend King Stock.

Key PointsKenvue is spending big to drum up demand for its diversified product portfolio.The companys weak results reflect pressure on…

Should You Buy Johnson & Johnson Stock Before July 16th?

Key PointsJohnson & Johnson reports earnings on Wednesday.Investors may be paying attention to tariff-related developments more so than the companys…

Andrew Hill Dumps 38,000 Johnson & Johnson Shares in Q2 2025 Exit

Key PointsThe investment advisor sold 38,037 shares for a total of $6.31 million in Q2 2025.Move removes JNJ from portfolio,…

This Stock Has Increased 4,720%: Heres Why Its Still a Buy

Key PointsJohnson & Johnson has delivered excellent returns to its long-term shareholders. One key factor behind the companys success is…

Motley Fool CEO Tom Gardner: S&P 500 (VOO) at 25× Earnings Is Stretching Valuations

Key PointsMotley Fool CEO Tom Gardner is worried that the "market" is a bit stretched valuation-wise.Gardner thinks there are still…

Johnson & Johnson (JNJ) Expected to Beat Earnings Estimates: Should You Buy?

Johnson & Johnson (JNJ) possesses the right combination of the two key ingredients for a likely earnings beat in its…

Looking to Generate Passive Income? Consider These 3 Rock-Solid Dividend King Stocks

Key PointsEmerson Electric has restructured its business to focus on long-term growth opportunities.Kenvue is a good choice for investors mainly…

Johnson Controls: Portfolio Transformation And Megatrends Support Re-Rating

…

Johnson Controls stock hits all-time high at 106.98 USD By Investing.com

Johnson Controls stock hits all-time high at 106.98 USD…

Heres Why Johnson & Johnson (JNJ) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Heres why…

Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Dividend Stock Instead?

Key PointsJohnson & Johnson is a Dividend King.The stock offers an attractive 3.4% dividend yield.Another healthcare stock has a 7.4%…

Why Johnson & Johnson (JNJ) Could Beat Earnings Estimates Again

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Is Most-Watched Stock Johnson & Johnson (JNJ) Worth Betting on Now?

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…

Top Analyst Reports for Johnson & Johnson, Home Depot and Micron

MU gains 42.5% YTD as AI demand fuels DRAM growth, while JNJ and HD navigate pricing, pipeline, and macro headwinds.…

Can Buying the Vanguard S&P 500 ETF Make You a Millionaire?

Buying an exchange-traded fund (ETF) that tracks an index like the S&P 500 can be a great way to build…

Johnson & Johnson (JNJ) Rises As Market Takes a Dip: Key Facts

Johnson & Johnson (JNJ) concluded the recent trading session at $155.92, signifying a +2.08% move from its prior days close.…

1 No-Brainer S&P Index Fund to Buy Right Now for Less Than $1,000

Exchange-traded funds (ETFs) make investing easy. While you may be able to make more money by investing in individual stocks,…

HDV Is a Popular Dividend ETF for Passive Income. But Is It the Best?

Artificial intelligence (AI), big tech, and cryptocurrencies all have their fans among investors, and with good reason. All can add…

DGRO Is a Popular Dividend ETF for Passive Income, but Is It the Best?

Many, if not most, of us would do well to include a bunch of dividend payers in our portfolio. Naturally,…

5 Vanguard ETFs to Buy With $1,000 and Hold Forever

Investing in exchange-traded funds (ETFs) is a great way for both new and experienced investors to gain market exposure, and…

Johnson & Johnson Is Great. Heres Why You Shouldnt Buy It.

Johnson & Johnson (NYSE: JNJ) is an iconic U.S. healthcare giant. It has changed over the years, but today its…

Johnson Outdoors Announces Cash Dividend

RACINE, Wis., June 26, 2025 (GLOBE NEWSWIRE) -- Johnson Outdoors Inc. (Nasdaq: JOUT), a leading global innovator of…

Johnson & Johnson: Undervalued Dividend King With 65% Upside Potential

…

5 Dividend Stocks Poised to Profit From the AI Efficiency Boom

When companies deploy artificial intelligence (AI) to streamline operations, the results can be staggering. Microsoft (NASDAQ: MSFT) is using AI-powered…

Zacks Investment Ideas feature highlights: Jabil, Apple, Amazon, Johnson & Johnson and Ericsson

Detailed price information for Jabil Circuit (JBL-N) from The Globe and Mail including charting and trades.…

Johnson & Johnson legt bei Umsatz und Gewinn zu

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) hat im ersten Quartal besser abgeschnitten…

ROUNDUP/Erneut juristischer Dämpfer für J&J: Keine Lösung für Babypuder-Klagen

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) muss im Streit um angebliche…

Juristische Watsche für J&J: Treuhandfonds für Babypuder-Klagen erneut abgelehnt

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) hat im Streit um…

Gutes Geschäft mit Krebsmedikamenten verleiht Johnson & Johnson Schub

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) hat im vergangenen Jahr die Umsatzeinbußen…

ROUNDUP: Johnson & Johnson übernimmt Intra-Cellular für Milliardensumme

NEW BRUNSWICK/BEDMINSTER (dpa-AFX) - Der US-Pharma- und Medizintechnikkonzern Johnson & Johnson (J&J) stärkt sich mit…

Kreise: Johnson & Johnson in Gesprächen zu Intra-Cellular-Übernahme

NEW YORK (dpa-AFX) - Der US-Pharma- und Medizintechnikkonzern Johnson & Johnson (J&J) ist Kreisen zufolge…